Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of VINC will rise by +0.79% over the next 2 Weeks and hit $0.01 by Monday, August 17, 2026. In that time frame, VINC's share price is expected to range between $0.01 and $0.01.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 17, 2026 | 0.01 | 0.01 | 0.01 |
| Aug 14, 2026 | 0.01 | 0.01 | 0.01 |
| Aug 13, 2026 | 0.01 | 0.01 | 0.01 |
| Aug 12, 2026 | 0.01 | 0.01 | 0.01 |
| Aug 11, 2026 | 0.01 | 0.01 | 0.01 |
| Aug 10, 2026 | 0.01 | 0.01 | 0.01 |
| Aug 7, 2026 | 0.01 | 0.01 | 0.01 |
| Aug 6, 2026 | 0.01 | 0.01 | 0.01 |
| Aug 5, 2026 | 0.01 | 0.01 | 0.01 |
| Aug 4, 2026 | 0.01 | 0.01 | 0.01 |
VINC shares remained flat 0 in Tuesday, August 4, 2026's trading session, starting and closing at a previous close of $0.01 to move at $0.01. The stock demonstrated notable intraday movement (see VINC's key stats for a full breakdown), fluctuating between $0.01 and $0.01, a 0 trading range. While recent weeks have seen some volatility, VINC has managed to secure a 0 no change over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 3.01K shares changing hands, 59.49K fewer than the previous session. This amounted to $38.27 in total market activity.
Will VINC Continue Its Upward Trend?
According to analyst ratings and projections for VINC, Vincerx Pharma, Inc. shares are anticipated to increase by +4.47%, potentially reaching $0.01 per share by August 17, 2026. Short-term technical indicators currently suggest a neutral sentiment for VINC. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 2 positive trading days within the past 30 sessions. Based on the VINC stock forecast, now is a good time to buy VINC stock because its current trading price is -0.78% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on VINC covering social and institutional perspectives.
VINC Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into VINC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 42.69% to 46.82%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 41.75%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.23%, maintains a neutral outlook for the long term. Insights into VINC's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Vincerx Pharma Short-Term Forecasts
VINC Forecast For Next 5 Days
Our algorithm anticipates Vincerx Pharma (VINC) stock could hit $0.01 by Aug 11, 2026. This represents a +6.30% fall from today's price, following a -1.02% change over the past five days.
VINC Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Vincerx Pharma, Inc. (VINC) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.01, which would mean a -21.26% decrease from the current price of $0.01. Projections for this period range from a high of $0.01 to a low of $0.01.
VINC Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Vincerx Pharma's price over the next three months point to a rise. VINC stock is expected to peak at $2.07 on Sep 24, 2026 before potentially dipping to $0.00 on Nov 04, 2026. On average, VINC is likely to trade around $0.03 in the coming 90 days.
Vincerx Pharma Stock Forecast 2025
Based on our predictive models, Vincerx Pharma (VINC) is expected to trade between $0.00 and $2.07 throughout 2026. This would result in an average price of $0.02, potentially offering investors a +57.48% return from current levels.
Vincerx Pharma, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Vincerx Pharma, Inc. (VINC) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $1.85, settling at an average of $0.05. This could translate to a +293.70% gain.
September 2026
Based on current market signals, Vincerx Pharma, Inc. is projected to trend september 2026. We forecast a trading range from $0.00 to $2.07, with a likely average price of $0.04. Investors could expect a potential return of +214.96%.
October 2026
Our predictive algorithms indicate Vincerx Pharma, Inc. stock may see a shift in October 2026. The expected range spans $0.00–$1.94, with an average target of $0.02. This represents a positive outlook and a possible gain of +57.48%.
November 2026
Analyzing established trends, Vincerx Pharma, Inc. looks set to move in November 2026. Projections place the stock between $0.00 and $1.73, averaging around $0.01. This suggests a -21.26% loss from current levels.
December 2026
Market indicators suggest Vincerx Pharma, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $1.79, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
January 2027
Forecasting for January 2027, models estimate that Vincerx Pharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.85, averaging $0.01. This signals a cautious trajectory with potential returns around -21.26%.
February 2027
According to our latest forecast models, Vincerx Pharma, Inc. (VINC) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $1.94, settling at an average of $0.01. This could translate to a -21.26% loss.
March 2027
Based on current market signals, Vincerx Pharma, Inc. is projected to trend march 2027. We forecast a trading range from $0.00 to $1.93, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
April 2027
Our predictive algorithms indicate Vincerx Pharma, Inc. stock may see a shift in April 2027. The expected range spans $0.00–$1.91, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
May 2027
Analyzing established trends, Vincerx Pharma, Inc. looks set to move in May 2027. Projections place the stock between $0.00 and $1.89, averaging around $0.00. This suggests a -100.00% loss from current levels.
June 2027
Market indicators suggest Vincerx Pharma, Inc. could experience notable changes during June 2027. Prices could fluctuate within $0.00 to $1.83, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
July 2027
Forecasting for July 2027, models estimate that Vincerx Pharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.53, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
August 2027
According to our latest forecast models, Vincerx Pharma, Inc. (VINC) is positioned to show a strong performance in August 2027. The price is predicted to move between $0.00 and $1.32, settling at an average of $0.00. This could translate to a -100.00% loss.
VINC's history of dividends and stock splits also plays a role in long-term investor confidence.